Systematic Ambulatory ECG Monitoring for Preventing Life-Threatening Cardiovascular Events Following TAVR

Area of Science:

• Cardiology
• Medical Devices
• Clinical Research

Background:

• Transcatheter aortic valve replacement (TAVR) is a common procedure for aortic stenosis.
• The role of ambulatory ECG (AECG) monitoring post-TAVR in preventing major adverse cardiovascular events is not well-established.
• Understanding the impact of systematic AECG monitoring is crucial for optimizing post-TAVR care.

Purpose of the Study:

• To determine if systematic 14-day AECG monitoring after TAVR reduces the incidence of life-threatening cardiovascular events within one year.
• To compare the rates of sudden cardiac death, syncope/presyncope due to arrhythmias, and stroke between patients with and without systematic AECG monitoring.

Main Methods:

• A cohort study involving 1217 patients who underwent TAVR without a permanent pacemaker.
• A group of 211 patients received systematic 14-day AECG monitoring (RECORD registry).
• A control group of 1006 patients did not receive systematic AECG monitoring.

Main Results:

• Systematic AECG monitoring was associated with a significantly lower incidence of the primary composite end point (1.9% vs. 6.6%, aHR 0.27).
• This reduction was primarily driven by lower rates of sudden death or arrhythmic syncope/presyncope (0.9% vs. 4.0%, aHR 0.22).
• New-onset atrial fibrillation was higher in the AECG group (8.9% vs. 1.8%), leading to increased oral anticoagulation use.

Conclusions:

• Systematic AECG monitoring post-TAVR facilitates earlier detection of severe arrhythmias.
• This monitoring strategy is linked to a reduction in life-threatening cardiovascular events within the first year.
• Findings suggest the need for a randomized controlled trial to confirm these benefits.